Triple-negative breast cancer (TNBC) refers to a molecular subtype of breast cancer that lacks the expression of both hormone receptors, the estrogen receptor (ER) and the progesterone receptor (PR), in addition to lacking the human epidermal growth factor receptor 2 (HER2) [1]. This evidence concerns the gene ESR1 and breast carcinoma.